We have succeeded in optimizing this approach to an extent by showing, in a previous study, its utility for the differentiation of HD patients from controls using blood serum.87 It is possible that similar SERS led optimization may enable the detection of tau conformers to enhance the stratification of tauopathies in the future, which may improve the accuracy of disease prognosis. The gene discussed is MAPT; the disease is Huntington disease.